Lassen Therapeutics is a pioneering brand dedicated to developing cutting-edge biotherapeutics that significantly enhance the lives of patients grappling with severe illnesses. With a focus on innovation and leveraging advanced technology, we are committed to creating novel medicines that address critical unmet medical needs. At Lassen Therapeutics, our lead program centers around interleukin-11 (IL-11), a cytokine that plays a pivotal role in fibrosis and the tumor microenvironment in certain cancers.

By targeting IL-11, we aim to bring forth breakthrough therapeutics with the potential to revolutionize treatments for a range of serious diseases. Supported by our team's profound expertise and a robust antibody development platform, we are actively advancing our pipeline of innovative therapeutics. Transparency, collaboration, and respect drive our operations.

We are passionately dedicated to improving the lives of patients and are proud to be at the forefront of creating life-improving medicines. Stay updated with our latest breakthroughs and achievements as we continue our mission to transform healthcare and make a lasting impact on the lives of patients. Join us in our journey towards a better future